¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop : 2024-02-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop : 2024-02-24
±³À°ÀÏÀÚ : 2024-02-24
±³À°Àå¼Ò : °í·Á´ëÇб³ À¯±¤»çȦ

±³À°ÁÖÁ¦ : KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop

ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸

´ã´çÀÚ : ±èÇý¼÷
¿¬¶ôó : 02-512-5420

À̸ÞÀÏ : kelly.kim1436@gmail.com

±³À°Á¾·ù : »êºÎÀΰú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:00~09:15 Gynecologic Oncology Group Foundation ¹é¹ÎÇö(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:15~09:30 Gynecologic Cancer InterGroup ÀÌ»êÈñ(¿øÁֱ⵶¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:30~09:45 European Network of Gynaecological Oncological Trial groups (ENGOT) ÀÌÁöÇö(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:45~10:00 East Asian Gynecologic Oncology Trial Group (EAGOT)¡¡& Asia-Pacific Gynecologic Oncology Trials Group (APGOT) ÇÑ°æÈñ(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 10:20~10:35 Exploring Minimally Invasive Surgical Approaches in Cervical cancer Trials ±è¸í¼±(¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 10:35~10:50 Advancements in Low-Risk Early-Stage Cervical Cancer Trials ±èÀºÅÃ(°í½Å´ëÇб³º¹À½º´¿ø)

Åä·Ð 02¿ù 24ÀÏ À¯±¤»çȦ 10:50~11:05 Panel discussion including ROCC trial ¼Û¹ÎÁ¾±è±âµ¿ÀÓ¸íö(¿©Àǵµ¼º¸ðº´¿øºÐ´ç¼­¿ï´ëÇб³º´¿ø±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 11:50~12:10 Pembrolizumab in Cervical Cancer: KEYNOTE-826 Insights & Sub-Analyses at ASCO, ESGO, ASGO 2023 À̸¶¸®¾Æ(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:10~13:25 KGOG 1047-Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK Trial) ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:25~13:40 KGOG 1036-Prospective-specimen-collection and retrospective blinded-evaluation study of HPV viral load to improve cervical cancer screening ±è¹ÎÁ¤(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:40~13:55 KGOG 1037-Retrospective-Impact of metformin of medication on survival outcome of cervical cancer ¹é¹ÎÇö(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:55~14:10 KRC-01-C01-A Phase 1/2 Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 Intratumoral Injection Combined with Radiotherapy in Patients with Locally Advanced Cervical Cancer Á¶¿¬¾Æ(°­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 14:10~14:30 Revolutionizing Oncology : The Paradigm of Cancer Immunotherapy À̼öÁ¤(°æºÏ´ëÇб³Ä¥°îº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 14:30~14:50 Precision Therapeutics : Navigating the Landscape of Antibody Drug Conjugates ±è¼±¿µ(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 02¿ù 24ÀÏ À¯±¤»çȦ 14:50~15:10 Panel discussion ¹Ú¿µÇÑÃÖöÈƱè°Ç¹Î(ÇѸ²´ë¼º½Éº´¿ø»ï¼º¼­¿ïº´¿ø¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 15:30~15:45 KGOG 1028S-Radiotherapy versus Observation in intermediate risk patients after Radical hysterectomy for early cervical cancer : Ancillary analysis of a Korean Gynecologic Group Study ½É½ÂÇõ(°Ç±¹´ëº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 15:45~16:00 KGOG 1046-Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer : a phase 3 trial ½É½ÂÇõ(°Ç±¹´ëº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 16:00~16:15 KGOG 1044-Feasibility of HPV DNA and vaginal infectious disease detection in mail-delivered self obtained vaginal sample obtained by G+KitⓇ ±è¹®È«(¿øÀڷº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 16:15~16:30 KGOG 1038-Phase II study of Belotecan monotherapy in patients with recurrent of persistent cervical cancer À̱¤¹ü(°¡ÃµÀÇ´ë±æº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop : 2024-02-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û â¿øƯ·Ê½Ãâ¿øÀÇ»çȸ ȸ¿ø¿¬¼ö±³À° : 2024-02-24
´ÙÀ½±Û 2024 ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ CISL : 2024-02-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20717 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_2ÀÏÂ÷) : 2024-06-01 0 97 2024-05-26
20716 ¼­¿ï 2024 ´ëÇѵΰæºÎ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-01 0 62 2024-05-26
20715 ¼­¿ï Á¦41Â÷ ´ëÇÑÁ¢ÃËÇǺο°¡¤¾Ë·¹¸£±âÇÐȸ Çмú´ëȸ : 2024-06-01 0 62 2024-05-26
20714 ¼­¿ï ´ëÇÑÃÖ¼Òħ½ÀôÃßÇÐȸ 2024 KOMISS Advanced Spinal Course Symposium & Cadaver Workshop : 2024-06-01 0 49 2024-05-26
20713 ¼­¿ï ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ Á¦38Â÷ Ãá°èÅëÇÕÇмú´ëȸ ¹× ¿¬¼ö±³À° (1ÀÏÂ÷) : 2024-05-31 0 104 2024-05-25
20712 ºÎ»ê »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ KSBMB International Conference 2024(3ÀÏÂ÷) : 2024-05-31 0 53 2024-05-25
20711 ºÎ»ê 2024 ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ ºÎ»ê¿ï»ê°æ³² ±³À°½ÉÆ÷Áö¿ò : 2024-05-31 0 67 2024-05-25
20710 ¼­¿ï (¿Â¶óÀÎ) 2024 ´ëÇÑÀÀ±ÞÀÇ·áÁöµµÀÇ»çÇùÀÇȸ ÁöµµÀÇ»ç Ãá°è¿¬¼ö°­Á : 2024-05-31 0 91 2024-05-25
20709 °æ±â Àü¹®½ÉÀå¼Ò»ý¼ú(ACLS Provider) ½Ã¹Ä·¹À̼Ç(1day) : 2024-05-31 0 74 2024-05-25
20708 ¼­¿ï ´ëÇÑÃÖ¼Òħ½ÀôÃßÇÐȸ 2024 KOMISS Advanced Spinal Course Symposium & Cadaver Workshop : 2024-05-31 0 77 2024-05-25
20707 °æ±â (¿Â¶óÀÎ) ºÐ´ç¼­¿ï´ëÇб³º´¿ø °íÀ§Çè»ê¸ð½Å»ý¾ÆÅëÇÕÄ¡·á ¿ù·ÊÁý´ãȸ : 2024-05-30 0 90 2024-05-25
20706 ºÎ»ê »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ KSBMB International Conference 2024(2ÀÏÂ÷) : 2024-05-30 0 37 2024-05-25
20705 ÀüºÏ ÀüÁÖ½ÃÀÇ»çȸ Ãá°è Çмú´ëȸ(´ç´¢º´, Ç×Ç÷¼ÒÆÇÁ¦, Ç㸮ÅëÁõ, ºñŸ¹ÎD¿Í Ä®½·) : 2024-05-30 0 49 2024-05-25
20704 ºÎ»ê »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ KSBMB International Conference 2024(1ÀÏÂ÷) : 2024-05-29 0 49 2024-05-25
20703 ¼­¿ï °­¼­±¸ÀÇ»çȸ ¿¬¼ö±³À°(õ½ÄÄ¡·á, °ñ´Ù°øÁõ, ÀÇ·áÇö½Ç) : 2024-05-29 0 50 2024-05-25
31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷